An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects
- 3 April 2009
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 24 (9) , 1375-1380
Abstract
There is evidence that GABAergic anticonvulsants can be efficacious in the treatment of alcohol dependence and in the prevention of alcohol relapse because these agents act on the substrate that is involved in alcoholism. Tiagabine, a selective GABA transporter1 reuptake inhibitor, may be a promising candidate for the treatment of alcohol-dependent individuals. In this randomized, open pilot study, we aimed to investigate the efficacy and tolerability of tiagabine as adjunctive treatment of alcohol-dependent individuals (N = 60) during the immediate post-detoxification period and during a 6-month follow-up period following alcohol withdrawal. A control non-medicated group of alcohol-dependent individuals (N = 60) was used for comparisons in terms of anxiety and depressive symptoms, craving and drinking outcome. Although a steady improvement in terms of psychopathology, craving and global functioning was observed in both groups throughout the study, subjects on tiagabine improved significantly more compared to the control subjects (P < 0.001). Furthermore, the relapse rate in the tiagabine group was lower than in the control group (7 vs 14.3%). Tiagabine was well tolerated and only a minority of the participants reported some adverse effects in the beginning of tiagabine treatment. Results from this study suggest that tiagabine is a safe and effective medication for the management of alcohol dependence when given adjunctively to a standard psychotherapy treatment. Further studies are warranted before definite conclusions can be reached.Keywords
This publication has 30 references indexed in Scilit:
- Using Topiramate or Naltrexone for the Treatment of Alcohol‐Dependent PatientsAlcohol, Clinical and Experimental Research, 2008
- Glutamatergic substrates of drug addiction and alcoholismBiochemical Pharmacology, 2008
- Gabapentin Reduces Alcohol Consumption and CravingThe Journal of Clinical Psychiatry, 2007
- Tiagabine does not attenuate alcohol-induced activation of the human reward systemPsychopharmacology, 2007
- IMPACT OF CRAVING ON ALCOHOL RELAPSE DURING, AND 12 MONTHS FOLLOWING, OUTPATIENT TREATMENTAlcohol and Alcoholism, 2004
- CDT, GGT, and AST As Markers of Alcohol Use: The WHO/ISBRA Collaborative ProjectAlcohol, Clinical and Experimental Research, 2002
- The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disordersAlcohol and Alcoholism, 2001
- Suppression of Ethanol-Reinforced Behavior by Naltrexone Is Associated with Attenuation of the Ethanol-Induced Increase in Dialysate Dopamine Levels in the Nucleus AccumbensJournal of Neuroscience, 1998
- Ethanol tolerance and synaptic plasticityTrends in Pharmacological Sciences, 1998
- The Obsessive Compulsive Drinking Scale: A Self‐Rated Instrument for the Quantification of Thoughts about Alcohol and Drinking BehaviorAlcohol, Clinical and Experimental Research, 1995